Position：Home >> Agenda
>> Sep.25th
>> International Science & Technology Cooperation Forum on Biomedicine for Prevention and Control of Infectious Diseases
| 14:00-14:10 | Welcoming Remarks |
| Moderator: Xu Jiajun, Deputy Director General, Foreign Talent Research Center, MOST | |
| 14:00-14:05 | Remarks by LI Xin, Deputy Director General, Department of Foreign Expert Services, MOST |
| 14:05-14:10 | Remarks by LANG Lin, Deputy Director, Policy, Advocacy and Government Relations, China Country Office, Bill & Melinda Gates Foundation |
| 14:10-16:30 | Keynote Speech |
| Moderator: LI Xin, Deputy Director General, Department of Foreign Expert Services, MOST | |
| 14:10-14:30 | Speech Topic: Brief Talk on Importance of Global Cooperation in Epidemic Prevention under the Influence of COVID-19. Dominique Bertrand (France), President of French National Commission of Public Health |
| 14:30-14:50 | Speech Topic: Study on Recombinant Vaccine against COVID-19 Based on New Adjuvants. XIA Ningshao, Dean of School of Public Health, Xiamen University |
| 14:50-15:10 | Speech Topic: Global Innovations in Manufacturing Technologies for Pandemic Vaccine Responses. David K Robinson (the United States), Deputy Director, Vaccine Development and Surveillance, Bill & Melinda Gates Foundation |
| 15:10-15:30 | Speech Topic: Evidence Demand for Vaccine Policy Making and Real-world Research. AN Zhijie, Deputy Director of National Immunization Program, Chinese Center for Disease Control and Prevention |
| 15:30-15:50 | Speech Topic: Global Cooperation in Prevention and Control of Major Infectious Diseases. Mark Jit (the United Kingdom), Professor from London School of Hygiene & Tropical Medicine, University of London |
| 15:50-16:10 | Speech Topic: “Made in China, Benefit the World” — GHDDI's Exploration in International Cooperation of Drug Research & Development. LU Manchun, Chief Operating Officer of Global Health Drug Discovery Institute |
| 16:10-16:30 | Speech Topic: Global Cooperation in Prevention and Control of Major Infectious Diseases. Garcon Nathalie (Belgium), CEO of Bioaster |
| 16:30-16:40 | Tea Break (Group Photo) |
| 16:40-17:40 | Panel Discussion |
| Moderator: XU Fujie, Deputy Director, Health, Innovation & Partnership, China Country Office, Bill & Melinda Gates Foundation | |
| Honored Guests: Luca Falqui (Italy), Health Coordinator ICRC Regional Delegation for East Asia Andrew Wong (the United States), General Manager, Shanghai Wotai Biotechnology Co., Ltd., a Walvax company Jean-Marc Bovet (Switzerland), Chief Technical Officer of CF PharmaTech Inc. FENG Luzhao, Executive Deputy Dean, School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College GAO Lei, Principal Investigator from the Institute of Pathogen Biology of Chinese Academy of Medical Sciences & Peking Union Medical College DONG Jian (the United States), CEO of WuXi Vaccines and SVP of WuXi biologics |
Focus On Us
Weibo
WeChat
